# VASOPRESSIN
> **ANDA212945** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL EU LTD · Approved 2022-08-10
## Drug
- **FDA Application Number:** ANDA212945
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VASOPRESSIN
- **Generic name:** Vasopressin
- **Active ingredients:** VASOPRESSIN
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** AMNEAL EU LTD
- **First approval:** 2022-08-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212945)
---
*AI Analytics · CC0 1.0*